Phase II clinical trial using anti-CD3 × anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) consolidation therapy for HER2 negative (0–2+) metastatic breast cancer
=====================================================================================================================================================================================

* Lawrence G. Lum
* Zaid Al-Kadhimi
* Abhinav Deol
* Vidya Kondadasula
* Dana Schalk
* Elyse Tomashewski
* Patricia Steele
* Kristie Fields
* Melissa Giroux
* Qin Liu
* Lawrence Flaherty
* Michael Simon
* Archana Thakur